FDA action on medication labeling information

fda-blog-700

By Dr Nicola Davies

Labeling information, including product inserts, are important components of marketed drug products. Clear and complete labeling information is critical for both health professionals and patients to make informed decisions. It also ensures consumers are aware of the correct use of these medications to maintain safety and achieve the intended effectiveness. The importance of appropriate labeling information is highlighted by the US Food and Drug Administration’s recent actions to optimize labeling content for prescription drugs, including biologicals.

Action by the FDA

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical